Pipamperone

Drugbox
IUPAC_name = "1- [4-(4-fluorophenyl)-4-oxo-butyl] -4-
(1-piperidyl)piperidine-4-carboxamide"

---

width = 140
CAS_number =
ATC_prefix = N05
ATC_suffix = AD05
ATC_supplemental =
PubChem = 4830
DrugBank =
C = 21 | H = 30 | F = 1 | N = 3 | O = 2
molecular_weight = 375.480 g/mol
bioavailability =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
legal_status =
routes_of_administration = Oral

Pipamperone is an antipsychotic drug (a butyrophenone derivative) used in the treatment of schizophrenia. Pipamperone is known to the general public under the marketed brand name Dipiperon.

Pipamperone was discovered at Janssen Pharmaceutica in 1960.

References

* Fouks, Mathis, Gilbert, Ferragu, Houssait, Lerno, Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone, Ann Med Psychol (Paris). 1966 Dec;124(5):677-81.
* Deberdt R., Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation, Acta Psychiatr Belg. 1976 Jan-Feb;76(1):157-66.